Nicaragua vs Somalia: HIV/AIDS deaths averted by antiretroviral therapy
Nicaragua
333 deaths
in 2022
Somalia
336.41 deaths
in 2022
Nicaragua rank
100th
Somalia rank
98th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Nicaragua
- Somalia
How they compare
Somalia currently reports 336.41 deaths against 333 deaths in Nicaragua, a difference of 3.41 deaths.
The two have swapped places 2 times across 33 shared years of data; in 1990 it was Somalia ahead.
Nicaragua ranks 100th and Somalia ranks 98th of 157 countries.
Nicaragua has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Nicaragua | Somalia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 55.8 deaths | 33.63 deaths | 22.17 deaths | Nicaragua |
| 2010s | 288.7 deaths | 264.05 deaths | 24.65 deaths | Nicaragua |
| 2020s | 346 deaths | 331.82 deaths | 14.18 deaths | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Nicaragua or Somalia?
- Somalia, at 336.41 deaths against 333 deaths in Nicaragua as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Nicaragua and Somalia?
- 3.41 deaths, with Somalia ahead.
- How many years of comparable data are there for Nicaragua and Somalia?
- 33 years are reported by both, from 1990 to 2022.
- How do Nicaragua and Somalia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Nicaragua ranks 100th and Somalia ranks 98th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.